heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with org 2766 in 1 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (org 2766) | Trials (org 2766) | Recent Studies (post-2010) (org 2766) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 204 | 36 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brakkee, JH; De Lannoy, LM; Gispen, WH; Merkus, FW; Romeijn, SG; Schipper, NG; Verhoef, JC; Wiegant, VM | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and org 2766
| Article | Year |
|---|---|
Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
Topics: Absorption; Administration, Intranasal; Adrenocorticotropic Hormone; Animals; beta-Cyclodextrins; Cyclodextrins; Drug Interactions; Male; Nasal Mucosa; Nerve Regeneration; Peptide Fragments; Peripheral Nerves; Rabbits; Rats; Rats, Wistar | 1993 |